Search Within

David Scheinberg

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (7)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  3. Center for Hematologic Malignancies (7)
  4. Department of Medicine (7)
  5. GSK Faculty (7)
  6. Hematologic Malignancies Research (7)

More Groups

People
  1. Christopher Klebanoff (4)
  2. Martin Klatt (4)
  3. Smita Chandran (4)
  4. Ron Gejman (3)
  5. Aaron Chang (2)
  6. Abraham Hakimi (2)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (1)
  5. 2016 (2)
Publications
  1. Cancer Immunology Research (1)
  2. Genome Biology (1)
  3. Journal for ImmunoTherapy of Cancer (1)
  4. Molecular Cancer Therapeutics (1)
  5. Nature Medicine (1)
  6. Nature Reviews Disease Primers (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Biomed Central Ltd (2)
  3. Nature Publishing Group (2)
  4. eLife Sciences Publications Ltd. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
    Journal Article

    Chandran, S. S.; Ma, J.; Klatt, M. G.; Dündar, F.; Bandlamudi, C.; Razavi, P.; Wen, H. Y.; Weigelt, B.; Zumbo, P.; Fu, S. N.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Identification of the targets of T-cell receptor therapeutic agents and cells by use of a high-throughput genetic platform
    Journal Article

    Gejman, R. S.; Jones, H. F.; Klatt, M. G.; Chang, A. Y.; Oh, C. Y.; Chandran, S. S.; Korontsvit, T.; Zakahleva, V.; Dao, T.; Klebanoff, C. A.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Rejection of immunogenic tumor clones is limited by clonal fraction
    Journal Article

    Gejman, R. S.; Chang, A. Y.; Jones, H. F.; DiKun, K.; Hakimi, A. A.; Schietinger, A.; Scheinberg, D. A.
    eLife (2018)

    Fulltext@MSK | Save
  • Acute myeloid leukaemia
    Journal Article

    Khwaja, A.; Bjorkholm, M.; Gale, R. E.; Levine, R. L.; Jordan, C. T.; Ehninger, G.; Bloomfield, C. D.; Estey, E.; Burnett, A.; Cornelissen, J. J.; more...
    Nature Reviews Disease Primers (2016)

    Fulltext@MSK | Save
  • Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
    Journal Article

    Şenbabaoğlu, Y.; Gejman, R. S.; Winer, A. G.; Liu, M.; Van Allen, E. M.; de Velasco, G.; Miao, D.; Ostrovnaya, I.; Drill, E.; Luna, A.; more...
    Genome Biology (2016)

    Fulltext@MSK | Save